Jinpu Zhu
Biographic Data
| ID | 7293544 |
|---|---|
| NAME | Jinpu Zhu |
| GIVEN NAMES | Jinpu |
| FAMILY NAME | Zhu |
| SIGNATURE | ZHU J |
| AFFILIATIONS | Changchun University of Chinese Medicine |
| ORCID | 0009-0005-8513-2073 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
No prominent works on this page.
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
Airway (1 works) · Airway hyperresponsiveness (1 works) · Asthma (1 works) · Bronchial hyperresponsiveness (1 works) · Homeostasis (1 works) · Inflammasome and immune disorders (1 works) · Inflammation (1 works) · Inhalation and Respiratory Drug Delivery (1 works) · Ion Channels and Receptors (1 works)